Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma

被引:0
作者
Ying Jin
Xin An
Yu Chen Cai
Ye Cao
Xiu Yu Cai
Qing Xia
Yu Ting Tan
Wen Qi Jiang
Yan Xia Shi
机构
[1] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China and Department of Medical Oncology
来源
Journal of Cancer Research and Clinical Oncology | 2011年 / 137卷
关键词
Bone metastases; Chemotherapy; Nasopharyngeal carcinoma; Survival benefit; Zoledronic acid;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1545 / 1551
页数:6
相关论文
共 170 条
[1]  
Au E(1994)A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma Ann Oncol 5 87-89
[2]  
Ang PT(2011)Treatment for metastatic nasopharyngeal carcinoma Eur Ann Otorhinolaryngol Head Neck Dis 128 79-85
[3]  
Bensouda Y(2000)Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases Cancer Res 60 2949-2954
[4]  
Kaikani W(2001)The treatment of distant metastases in head and neck cancer–present and future ORL J Otorhinolaryngol Relat Spec 63 259-264
[5]  
Ahbeddou N(2002)Nasopharyngeal carcinoma Ann Oncol 13 1007-1015
[6]  
Rahhali R(2006)The enigmatic epidemiology of nasopharyngeal carcinoma Cancer Epidemiol Biomarkers Prev 15 1765-1777
[7]  
Jabri M(2001)Distant metastases from nasopharyngeal cancer ORL J Otorhinolaryngol Relat Spec 63 214-216
[8]  
Mrabti H(2008)Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma Head Neck 30 863-867
[9]  
Boussen H(2005)Anti-tumour activity of zoledronic acid Cancer Treat Rev 31 1-8
[10]  
Errihani H(2003)The anti-tumor potential of zoledronic acid Breast 12 S30-S36